Immuneering (IMRX) Shares Outstanding (Diluted Average): 2020-2024
Historic Shares Outstanding (Diluted Average) for Immuneering (IMRX) over the last 5 years, with Sep 2024 value amounting to $29.8 million.
- Immuneering's Shares Outstanding (Diluted Average) rose 1.97% to $29.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.8 million, marking a year-over-year increase of 1.97%. This contributed to the annual value of $28.4 million for FY2023, which is 7.69% up from last year.
- Per Immuneering's latest filing, its Shares Outstanding (Diluted Average) stood at $29.8 million for Q3 2024, which was up 0.64% from $29.7 million recorded in Q2 2024.
- Immuneering's 5-year Shares Outstanding (Diluted Average) high stood at $29.8 million for Q3 2024, and its period low was $5.0 million during Q2 2020.
- Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $28.4 million (2023), whereas its average is $27.9 million.
- Data for Immuneering's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 432.57% (in 2022) over the last 5 years.
- Immuneering's Shares Outstanding (Diluted Average) (Quarterly) stood at $5.0 million in 2020, then spiked by 175.00% to $13.6 million in 2021, then surged by 93.84% to $26.4 million in 2022, then rose by 7.69% to $28.4 million in 2023, then climbed by 1.97% to $29.8 million in 2024.
- Its Shares Outstanding (Diluted Average) was $29.8 million in Q3 2024, compared to $29.7 million in Q2 2024 and $29.4 million in Q1 2024.